Agilon Health, Inc. (NYSE:AGL) Receives Average Rating of “Hold” from Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have been assigned an average rating of “Hold” from the fourteen research firms that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $64.00.

Several research firms recently commented on AGL. Robert W. Baird raised their price target on shares of Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective for the company. in a research report on Monday, May 4th. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. TD Cowen restated a “hold” rating and set a $55.00 target price (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Finally, Citigroup restated a “neutral” rating and set a $80.00 target price (up from $18.75) on shares of Agilon Health in a research report on Friday, May 15th.

Agilon Health Trading Down 4.3%

Agilon Health stock opened at $120.42 on Thursday. The firm has a market cap of $2.01 billion, a PE ratio of -5.59 and a beta of 2.98. Agilon Health has a 12 month low of $7.48 and a 12 month high of $133.04. The stock’s 50 day simple moving average is $104.22 and its two-hundred day simple moving average is $49.97. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. Analysts anticipate that Agilon Health will post -3.5 earnings per share for the current year.

Institutional Trading of Agilon Health

Institutional investors have recently bought and sold shares of the business. Alpine Global Management LLC acquired a new position in shares of Agilon Health during the 4th quarter worth approximately $84,000. North Peak Capital Management LLC grew its stake in Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after acquiring an additional 3,715,460 shares during the period. State of Wyoming grew its stake in Agilon Health by 64.9% in the 4th quarter. State of Wyoming now owns 359,664 shares of the company’s stock valued at $248,000 after acquiring an additional 141,572 shares during the period. Simplify Asset Management Inc. increased its holdings in Agilon Health by 92.0% in the 4th quarter. Simplify Asset Management Inc. now owns 218,810 shares of the company’s stock worth $151,000 after acquiring an additional 104,834 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in Agilon Health in the 4th quarter worth $1,408,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.